Jan C Ericksson

Title: **Jan C. Ericksson: Innovator in Medical Surface Treatments**

Introduction

Jan C. Ericksson, a notable inventor based in Djursholm, Sweden, has made significant contributions to the field of medical technology. His innovative approach to heparinization has potential applications in enhancing the safety and efficacy of medical articles intended for blood contact.

Latest Patents

Ericksson holds a patent for a method of heparinizing a charged surface of a medical article. This inventive technique involves treating the surface of such articles with a colloidal aqueous solution that combines heparin with a cationic surfactant. The unique aspect of this method lies in the particles of the colloidal solution possessing charges that are opposite to those of the article's surface, which can lead to improved blood compatibility and reduced thrombogenicity in medical devices.

Career Highlights

Jan C. Ericksson works at Aminkemi AB, a company focused on innovations in chemical solutions for the medical industry. His expertise and dedication to developing safer medical devices have established him as an influential figure in his field.

Collaborations

Throughout his career, Ericksson has collaborated closely with fellow inventor Rolf L. Larsson. Their partnership embodies a shared commitment to advancing medical technologies through innovative research and development.

Conclusion

With his pioneering work in heparinization methods, Jan C. Ericksson is making a significant impact on the safety and effectiveness of medical articles. His contributions through Aminkemi AB and collaborations with experts like Rolf L. Larsson underline the importance of innovation in the medical field. The advancements stemming from his research have the potential to enhance patient outcomes and redefine standards for medical devices.